Maghanoy, Rexcel .
HRN: 10-65-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2022
CEFUROXIME 500MG (TAB)
11/28/2022
12/06/2022
PO
500mg
Bid
Perineal Lacerations
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes